UniProt ID | UTP18_HUMAN | |
---|---|---|
UniProt AC | Q9Y5J1 | |
Protein Name | U3 small nucleolar RNA-associated protein 18 homolog | |
Gene Name | UTP18 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 556 | |
Subcellular Localization | Nucleus, nucleolus . | |
Protein Description | Involved in nucleolar processing of pre-18S ribosomal RNA.. | |
Protein Sequence | MPPERRRRMKLDRRTGAKPKRKPGMRPDWKAGAGPGGPPQKPAPSSQRKPPARPSAAAAAIAVAAAEEERRLRQRNRLRLEEDKPAVERCLEELVFGDVENDEDALLRRLRGPRVQEHEDSGDSEVENEAKGNFPPQKKPVWVDEEDEDEEMVDMMNNRFRKDMMKNASESKLSKDNLKKRLKEEFQHAMGGVPAWAETTKRKTSSDDESEEDEDDLLQRTGNFISTSTSLPRGILKMKNCQHANAERPTVARISSVQFHPGAQIVMVAGLDNAVSLFQVDGKTNPKIQSIYLERFPIFKACFSANGEEVLATSTHSKVLYVYDMLAGKLIPVHQVRGLKEKIVRSFEVSPDGSFLLINGIAGYLHLLAMKTKELIGSMKINGRVAASTFSSDSKKVYASSGDGEVYVWDVNSRKCLNRFVDEGSLYGLSIATSRNGQYVACGSNCGVVNIYNQDSCLQETNPKPIKAIMNLVTGVTSLTFNPTTEILAIASEKMKEAVRLVHLPSCTVFSNFPVIKNKNISHVHTMDFSPRSGYFALGNEKGKALMYRLHHYSDF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
41 | Ubiquitination | GPGGPPQKPAPSSQR CCCCCCCCCCCHHHC | 49.25 | 27667366 | |
41 | Acetylation | GPGGPPQKPAPSSQR CCCCCCCCCCCHHHC | 49.25 | 25953088 | |
45 | Phosphorylation | PPQKPAPSSQRKPPA CCCCCCCHHHCCCCC | 41.01 | 25849741 | |
46 | Phosphorylation | PQKPAPSSQRKPPAR CCCCCCHHHCCCCCC | 32.71 | 30266825 | |
55 | Phosphorylation | RKPPARPSAAAAAIA CCCCCCHHHHHHHHH | 25.61 | 20068231 | |
84 | Sumoylation | RLRLEEDKPAVERCL CCCHHCCCHHHHHHH | 37.85 | 28112733 | |
84 | Sumoylation | RLRLEEDKPAVERCL CCCHHCCCHHHHHHH | 37.85 | - | |
84 | Ubiquitination | RLRLEEDKPAVERCL CCCHHCCCHHHHHHH | 37.85 | 24816145 | |
121 | Phosphorylation | RVQEHEDSGDSEVEN CCCCCCCCCCCHHCH | 41.33 | 29255136 | |
124 | Phosphorylation | EHEDSGDSEVENEAK CCCCCCCCHHCHHHC | 47.25 | 29255136 | |
172 | Sumoylation | MKNASESKLSKDNLK HHHHCHHHCCHHHHH | 53.37 | - | |
172 | Sumoylation | MKNASESKLSKDNLK HHHHCHHHCCHHHHH | 53.37 | - | |
172 | Ubiquitination | MKNASESKLSKDNLK HHHHCHHHCCHHHHH | 53.37 | 33845483 | |
172 | 2-Hydroxyisobutyrylation | MKNASESKLSKDNLK HHHHCHHHCCHHHHH | 53.37 | - | |
172 | Acetylation | MKNASESKLSKDNLK HHHHCHHHCCHHHHH | 53.37 | 25953088 | |
175 | Sumoylation | ASESKLSKDNLKKRL HCHHHCCHHHHHHHH | 62.16 | - | |
175 | Ubiquitination | ASESKLSKDNLKKRL HCHHHCCHHHHHHHH | 62.16 | 24816145 | |
175 | Sumoylation | ASESKLSKDNLKKRL HCHHHCCHHHHHHHH | 62.16 | - | |
183 | Acetylation | DNLKKRLKEEFQHAM HHHHHHHHHHHHHHC | 60.27 | 26051181 | |
183 | Sumoylation | DNLKKRLKEEFQHAM HHHHHHHHHHHHHHC | 60.27 | - | |
183 | Sumoylation | DNLKKRLKEEFQHAM HHHHHHHHHHHHHHC | 60.27 | 28112733 | |
183 | Ubiquitination | DNLKKRLKEEFQHAM HHHHHHHHHHHHHHC | 60.27 | 29967540 | |
199 | Phosphorylation | GVPAWAETTKRKTSS CCCCHHHHCCCCCCC | 29.85 | 28555341 | |
201 | Ubiquitination | PAWAETTKRKTSSDD CCHHHHCCCCCCCCC | 60.35 | 29967540 | |
201 | Sumoylation | PAWAETTKRKTSSDD CCHHHHCCCCCCCCC | 60.35 | 28112733 | |
204 | Phosphorylation | AETTKRKTSSDDESE HHHCCCCCCCCCCCC | 37.18 | 22167270 | |
205 | Phosphorylation | ETTKRKTSSDDESEE HHCCCCCCCCCCCCC | 34.50 | 22167270 | |
206 | Phosphorylation | TTKRKTSSDDESEED HCCCCCCCCCCCCCC | 55.07 | 29255136 | |
210 | Phosphorylation | KTSSDDESEEDEDDL CCCCCCCCCCCHHHH | 53.96 | 29255136 | |
221 | Phosphorylation | EDDLLQRTGNFISTS HHHHHHHHCCCCCCC | 24.42 | 28112733 | |
226 | Phosphorylation | QRTGNFISTSTSLPR HHHCCCCCCCCCCCC | 16.50 | 20068231 | |
227 | Phosphorylation | RTGNFISTSTSLPRG HHCCCCCCCCCCCCC | 31.07 | 20068231 | |
228 | Phosphorylation | TGNFISTSTSLPRGI HCCCCCCCCCCCCCE | 14.81 | 20068231 | |
229 | Phosphorylation | GNFISTSTSLPRGIL CCCCCCCCCCCCCEE | 34.08 | 20068231 | |
230 | Phosphorylation | NFISTSTSLPRGILK CCCCCCCCCCCCEEH | 35.82 | 20068231 | |
239 | Ubiquitination | PRGILKMKNCQHANA CCCEEHHCCCCCCCC | 53.65 | 29967540 | |
283 | Ubiquitination | SLFQVDGKTNPKIQS EEEEECCCCCHHHEE | 40.44 | 23000965 | |
287 | Ubiquitination | VDGKTNPKIQSIYLE ECCCCCHHHEEEEEE | 56.28 | 23000965 | |
287 | Acetylation | VDGKTNPKIQSIYLE ECCCCCHHHEEEEEE | 56.28 | 26051181 | |
290 | Phosphorylation | KTNPKIQSIYLERFP CCCHHHEEEEEECCH | 19.37 | 20068231 | |
292 | Phosphorylation | NPKIQSIYLERFPIF CHHHEEEEEECCHHH | 14.04 | 20068231 | |
304 | Ubiquitination | PIFKACFSANGEEVL HHHHHHHCCCCCEEE | 22.25 | 21890473 | |
313 | Phosphorylation | NGEEVLATSTHSKVL CCCEEEEECCCCCEE | 29.96 | 28787133 | |
321 | Phosphorylation | STHSKVLYVYDMLAG CCCCCEEHHHHHHCC | 10.43 | - | |
329 | Ubiquitination | VYDMLAGKLIPVHQV HHHHHCCCEEEHHHH | 37.32 | 23000965 | |
340 | Ubiquitination | VHQVRGLKEKIVRSF HHHHCCCHHHHHEEE | 60.84 | 24816145 | |
346 | Ubiquitination | LKEKIVRSFEVSPDG CHHHHHEEEEECCCC | 18.18 | 21890473 | |
354 | Phosphorylation | FEVSPDGSFLLINGI EEECCCCCEEEECCH | 21.80 | - | |
364 | Phosphorylation | LINGIAGYLHLLAMK EECCHHHHHHHHHHH | 5.07 | - | |
372 | Phosphorylation | LHLLAMKTKELIGSM HHHHHHHHHHHHCCC | 19.37 | 29759185 | |
373 | Ubiquitination | HLLAMKTKELIGSMK HHHHHHHHHHHCCCE | 45.03 | 29967540 | |
389 | Phosphorylation | NGRVAASTFSSDSKK CCEEEEEEECCCCCE | 23.86 | 20860994 | |
395 | 2-Hydroxyisobutyrylation | STFSSDSKKVYASSG EEECCCCCEEEEECC | 51.77 | - | |
395 | Ubiquitination | STFSSDSKKVYASSG EEECCCCCEEEEECC | 51.77 | 21906983 | |
396 | Ubiquitination | TFSSDSKKVYASSGD EECCCCCEEEEECCC | 44.42 | 29967540 | |
412 | Ubiquitination | EVYVWDVNSRKCLNR CEEEEECCCCHHHHH | 33.36 | 21890473 | |
425 | Phosphorylation | NRFVDEGSLYGLSIA HHHCCCCCEEEEEEE | 19.17 | 28152594 | |
427 | Phosphorylation | FVDEGSLYGLSIATS HCCCCCEEEEEEEEC | 20.09 | 28152594 | |
430 | Phosphorylation | EGSLYGLSIATSRNG CCCEEEEEEEECCCC | 13.05 | 28152594 | |
433 | Phosphorylation | LYGLSIATSRNGQYV EEEEEEEECCCCCEE | 26.92 | 28152594 | |
434 | Phosphorylation | YGLSIATSRNGQYVA EEEEEEECCCCCEEE | 18.09 | 28152594 | |
517 | Ubiquitination | FSNFPVIKNKNISHV ECCCCEEECCCCCCE | 63.20 | 32015554 | |
517 | Acetylation | FSNFPVIKNKNISHV ECCCCEEECCCCCCE | 63.20 | 26051181 | |
517 | Sumoylation | FSNFPVIKNKNISHV ECCCCEEECCCCCCE | 63.20 | 28112733 | |
519 | Ubiquitination | NFPVIKNKNISHVHT CCCEEECCCCCCEEE | 51.13 | 33845483 | |
530 | Phosphorylation | HVHTMDFSPRSGYFA CEEECCCCCCCCEEE | 18.35 | 20873877 | |
535 | Phosphorylation | DFSPRSGYFALGNEK CCCCCCCEEEECCHH | 6.21 | - | |
536 | Ubiquitination | FSPRSGYFALGNEKG CCCCCCEEEECCHHH | 5.30 | 21890473 | |
542 | Acetylation | YFALGNEKGKALMYR EEEECCHHHHHHHHH | 70.48 | 26051181 | |
542 | Ubiquitination | YFALGNEKGKALMYR EEEECCHHHHHHHHH | 70.48 | 29967540 | |
554 | Phosphorylation | MYRLHHYSDF----- HHHHHCCCCC----- | 28.34 | 20873877 | |
559 | Ubiquitination | HYSDF---------- CCCCC---------- | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UTP18_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UTP18_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UTP18_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MPP10_HUMAN | MPHOSPH10 | physical | 26344197 | |
RBM19_HUMAN | RBM19 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121; SER-124; THR-204;SER-205; SER-206 AND SER-210, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-204; SER-205; SER-206AND SER-210, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121 AND SER-124, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121; SER-124; THR-204;SER-205; SER-206 AND SER-210, AND MASS SPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121 AND SER-124, ANDMASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121 AND SER-124, ANDMASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121 AND SER-124, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121 AND SER-124, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121 AND SER-124, ANDMASS SPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-121 AND SER-124, ANDMASS SPECTROMETRY. |